These findings, combined with our observation that synergistic effects can be observed when using DMC in combination with TRAIL in a subset of GBM cells, give us further insight in the pleiotropic nature of this class of compounds and their potential effects in further enhancing or sensitizing cancer cells to TRAIL-induced apoptosis. This evidence concerns the gene TNFSF10 and glioblastoma.